The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 2, 2009, Pages 89-93

  Diaz, Jeaneth ^a   Chedraui, Peter ^a,b   Hidalgo, Luis ^a   Medina, Marcela ^a  

^a Enrique C Sotomayor Obstetrics and Gynecology Hospital   (Ecuador)

^b UNIVERSIDAD CATÓLICA DE SANTIAGO DE GUAYAQUIL   (Ecuador)

Author keywords

Ecuador; Fetal fibronectin; Pre term birth; Prediction

Indexed keywords

FIBRONECTIN;

ARTICLE; DIAGNOSTIC VALUE; ECUADOR; FETUS; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREDICTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SOCIAL CLASS;

ADULT; BIRTH WEIGHT; CERVIX UTERI; DEVELOPING COUNTRIES; ECUADOR; FEMALE; FETUS; FIBRONECTINS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; LENGTH OF STAY; OBSTETRIC LABOR, PREMATURE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREMATURE BIRTH; SENSITIVITY AND SPECIFICITY;

EID: 67249134505     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050802464551     Document Type: Article

References (20)

1. Copper RL, Goldenberg RL, Creasy RK, DuBard MB, Davis RO, Entman SS, Iams JD, Cliver SP. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol 1993;168:78-84.
2. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993;15:414-443.
3. McLean M, Walters WA, Smith R. Prediction and early diagnosis of preterm labor: a critical review. Obstet Gynecol Surv 1993;48:209-225.
4. Berghella V, Hayes E, Visintine J, Baxter J. Fetal fibronectin testing for reducing the risk of preterm birth. (Protocol). Cochrane Database Syst Rev 2007;CD006843.
5. Smith V, Devane D, Begley CM, Clarke M, Higgins S. A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth. Eur J Obstet Gynecol Reprod Biol 2007;133:134-142.
6. GilesW, Bisits A, Knox M, Madsen G, Smith R. The effect of fetal fibronectin testing on admissions to a tertiary maternalfetal medicine unit and cost savings. Am J Obstet Gynecol 2000;182:439-442.
7. Joffe GM, Jacques D, Bemis-Heys R, Burton R, Skram B, Shelburne P. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 1999;180:581-586.
8. Shimoya K, Hashimoto K, Shimizu T, Saji F, Murata Y. Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions. Am J Obstet Gynecol 1998;179:255-256.
9. Ballard JL, Novak KK, Driver M. A simplified score for assessment of fetal maturation of newly born infants. J Pediatr 1979;95:769-774.
10. Paredes I, Hidalgo L, Chedraui P, Palma J, Eugenio J. Factors associated with inadequate prenatal care in Ecuadorian women. Int J Gynaecol Obstet 2005;88:168-172.
11. Available at: www.jbg.org.ec. (accessed 20 July 2008).
12. Chedraui PA, Hidalgo LA, San Miguel G. Cost analysis in a high risk pregnancy Unit. Int J Gynaecol Obstet 2003;83:53.
13. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones L, Deligdisch L, Garite TJ. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-674.
14. Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, Lockitch G. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141-145.
15. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, Coultrip L, Eriksen N, Holbrook RH, Elliott J, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997;177:13-18.
16. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 1996;87:643-648.
17. Tekesin I, Marek S, Hellmeyer L, Reitz D, Schmidt S. Assessment of rapid fetal fibronectin in predicting preterm delivery. Obstet Gynecol 2005;105:280-284.
18. Garcia Alonso LA, Jimenez SG, Ayala Mendez JA, Izquierdo Puente JC, Barahona BE. Clinical usefulness of fetal fibronectin (fFN) expression in cervico-vaginal secretions (CVS). Ginecol Obstet Mex 2002;70:379-384.
19. Garcia Alonso LA, Ayala Mendez JA, Jimenez Solis G, Aguilar Gutierrez F, Diaz Cueto L. Economical impact of preterm delivery management based on fetal fibronectin results. Ginecol Obstet Mex 2004;72:385-393.
20. Peláez LM, Fox NS, Chasen ST. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help? J Perinat Med 2008;36:202-205.